Expanded Programme on Immunization, Department of Immunization, Vaccines and Biologicals, World Health Organization, 1211 Geneva 27, Switzerland.
J Infect Dis. 2011 Jul;204 Suppl 1:S28-34. doi: 10.1093/infdis/jir095.
In response to repeated requests for assistance in evaluating the health benefit and cost implications of adjustments to national measles immunization strategies, the World Health Organization (WHO) has developed the Measles Strategic Planning (MSP) tool to harness routinely available data to estimate effectiveness and cost effectiveness of vaccination strategies.
The MSP tool estimates measles incidence and mortality through a country-specific cohort model, using a probability of infection dependent on population immunity levels. This method approximates measles transmission dynamics without requiring detailed data that would prohibit use in low- and middle-income countries. Coupled with cost data, the tool estimates incremental costs and cost effectiveness of user-defined vaccination strategies over 5-10 year planning periods.
The MSP tool produces valid estimates of measles incidence in settings with low to moderate vaccination coverage. Early adopters report that the tool facilitates decision making by minimizing the amount of time required to assess the impact of vaccination strategies on population immunity.
By clearly illustrating what vaccination strategies can effectively protect against measles at the least cost to immunization programs, the MSP tool supports evidence-based decision making for effective and comprehensive measles control.
针对反复请求协助评估调整国家麻疹免疫策略的健康效益和成本影响,世界卫生组织(世卫组织)开发了麻疹战略规划(MSP)工具,利用常规可获得的数据来估计疫苗接种策略的效果和成本效益。
MSP 工具通过特定国家的队列模型来估计麻疹发病率和死亡率,使用取决于人群免疫力水平的感染概率。这种方法近似麻疹传播动态,而无需详细数据,从而禁止在低收入和中等收入国家使用。结合成本数据,该工具可估算用户定义的疫苗接种策略在 5-10 年规划期内的增量成本和成本效益。
MSP 工具在疫苗接种覆盖率低至中等的环境中可产生有效的麻疹发病率估计。早期采用者报告说,该工具通过最小化评估疫苗接种策略对人群免疫力影响所需的时间,促进了决策制定。
通过清楚地说明哪些疫苗接种策略可以以最低的免疫规划成本有效地预防麻疹,MSP 工具支持基于证据的决策,以实现有效的全面麻疹控制。